Literature DB >> 7331999

Peritoneal clearance of theophylline.

G S Brown, T O Lohr, G H Mayor, J J Freitag, T V Sanchez, J M Prasad.   

Abstract

Clearance of theophylline was determined in 3 patients receiving maintenance theophylline during peritoneal dialysis. The average peritoneal dialysis clearance of theophylline was 11.67 ml/min. The average theophylline to creatinine clearance ratio was 0.85 representing significant clearance across the peritoneum. The amount of theophylline removed per exchange was approximately 8 mg. Charcoal or resin hemoperfusion and hemodialysis are undoubtedly the most efficient means of treating theophylline overdose. However, peritoneal dialysis appears to be a useful alternative as overdosed patients would be expected to have significantly higher serum concentrations than encountered in this study, greater gradients across the peritoneal membrane, and greater net removal of theophylline per exchange than reported here.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7331999     DOI: 10.1016/s0272-6386(81)80007-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

1.  Pharmacokinetics of theophylline and its metabolites in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  T B Vree; M Martea; R G Tiggeler; Y A Hekster; J C Hafkenscheid
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

Review 2.  Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.

Authors:  T W Paton; W R Cornish; M A Manuel; B G Hardy
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

Review 3.  Clinical toxicology.

Authors:  J A Vale
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

Review 4.  Role of extracorporeal drug removal in acute theophylline poisoning. A review.

Authors:  A Heath; K Knudsen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.